Tumour suppressor p53 has been shown to inhibit ®broblast growth factor 2 expression post-transcriptionally in cultured cells. Here we have investigated the mechanism responsible for this post-transcriptional blockade. Deletion mutagenesis of the FGF-2 mRNA leader revealed the requirement of at least four RNA cisacting elements to mediate the inhibitory eect of p53 in SK-Hep-1 transfected cells, suggesting the involvement of RNA secondary or tertiary structures. Recombinant wild-type, but not Ala 143 mutant p53, was able to speci®cally repress FGF-2 mRNA translation in rabbit reticulocyte lysate, in a dose dependent manner. Sucrose gradient experiments showed that p53 blocks translation initiation by preventing 80S ribosome formation on an mRNA bearing the FGF-2 mRNA leader sequence. Interaction of wild-type and mutant p53 with dierent RNAs showed no signi®cant correlation between p53 RNA binding activity and its translational inhibiting eect. However, by checking the accessibility of the FGF-2 mRNA leader to complementary oligonucleotide probes, we showed that the binding to RNA of wild-type, but not mutant p53, induced RNA conformational changes that might be responsible for the translational blockade. This strongly suggests that p53 represses FGF-2 mRNA translation by a direct mechanism involving its nucleic acid unwinding ± annealing activity. Oncogene (2001) 20, 4613 ± 4620.
Introduction
We have recently shown that the tumour suppressor p53 is able to inhibit the expression of chimeric FGF-CAT mRNAs by a post-transcriptional mechanism, independent of the activation of p53 target genes, which is speci®cally mediated by the FGF-2 mRNA 5' untranslated region (5' UTR; Galy et al., 2001) . That study did not elucidate, however, whether p53 acts by modulating the activity of trans-acting factors involved in the control of mRNA translation, or by direct interaction with the FGF-2 mRNA.
A few studies suggesting that p53 can repress translation by direct interactions are reported in the literature. p53 exhibits high anity for RNA (Oberosler et al., 1993) , and has been shown to repress translation of its own mRNA and that of the cdk4 mRNA, by a direct interaction (Miller et al., 2000; Mosner et al., 1995) . p53 has also been detected in polysomes preparations (Fontoura et al., 1997) . One can question the physiological relevance of the translational eect of a nuclear protein. However, some evidence has been reported that p53 can be transiently localized in the cytoplasm as a function of the cell cycle or cell dierentiation (Shaulsky et al., 1990; Moll et al., 1995) . Moreover, p53 is now known to possess a nuclear export signal in its tetramerization domain (Stommel et al., 1999) . Taken together these data favour the hypothesis that p53 might exhibit both nuclear and cytoplasmic functions.
We show here by transient SK-Hep-1 cell transfection that the p53 post-transcriptional inhibitory eect mediated by the FGF-2 mRNA leader requires at least four elements of the FGF-2 mRNA leader sequence, suggesting the involvement of RNA structures in the inhibitory mechanism. In vitro translation experiments were performed using recombinant wild-type (wt) or Ala 143 mutant p53, demonstrating a direct inhibition of FGF-2 translation by wt p53, occurring at the translation initiation step. The wt p53 enhanced the annealing of complementary oligonucleotides to the FGF-2 mRNA 5' UTR, thus revealing that it was able to induce an RNA conformational change.
Results
The post-transcriptional inhibitory effect of wt p53 requires at least four elements of the FGF-2 mRNA leader
To characterize the cis-elements involved in the repressor eect of wt p53, deletions were performed in the FGF-2 mRNA leader on the basis of secondary structure prediction to remove putative structural Oncogene (2001) 20, 4613 ± 4620 domains (data not shown). Bigenic vectors were used to co-express chimeric FGF-CAT mRNAs (target) with p53 eector, either wild-type (wt) or mutant (Ala 143 ) as described previously (Galy et al., 2001) . FGF-CAT protein expression in SK-Hep-1 cells co-expressing p53, calibrated on the RNA level, is presented in Figure 1b as the ratio of wt to mutant p53. Most of the deletions resulted in the abolition of the p53 inhibitory eect, except for deletion of the segment 252 ± 311 (located just upstream from the CUG1 codon) or 376 ± 466 (between CUG3 and AUG codons) (Figure 1c , boxes A and B). In conclusion, the inhibitory eect of p53 necessitates at least four distincts elements within the FGF-2 mRNA leader, that are located within the segments 1 ± 76, 126 ± 176, 176 ± 221 and 311 ± 376, respectively (Figure 1c, boxes I to IV) . This suggests that translation inhibition by p53 is mediated by RNA secondary or tertiary structures rather than by a speci®c RNA sequence target.
wt p53 inhibits translation initiation of a chimeric FGF-CAT mRNA in a cell free system
To evaluate the ability of p53 to directly modulate or not FGF-2 mRNA translation, we studied the eects of recombinant p53 on the translation of a chimeric FGF-CAT mRNA in vitro. Human wt p53 or Ala 143 mutant p53 were produced in the baculovirus expression system (as described in Materials and methods). Increasing amounts of recombinant proteins were preincubated with FGF-CAT or control RNAs for 15 min at 378C prior to the addition of rabbit reticulocyte lysate (RRL). The eciency of FGF-CAT translation was inversely correlated with the amount of added wt p53 (Figure 2a, upper left panel) . In contrast, equal amounts of Ala 143 mutant protein had little or no eect (Figure 2a, upper right panel) . The integrity of the FGF-CAT RNA was checked to rule out a possible RNA destabilization by wt p53 (Figure 2a , lower panels). As expected, the 5'-UTR of the mouse p53 mRNA mediated an inhibitory eect of wt p53 on CAT translation (Figure 2b , upper left panel) (Mosner et al., 1995) whereas translation of CAT or luciferase mRNAs under the same conditions was not signi®cantly aected by wt p53 (Figure 2b , middle left panel and lower left panel, respectively). Furthermore, deletion of the ®rst 186 nt of the FGF-2 RNA leader in the FGF-CAT chimeric RNA abolished the inhibitory eect of wt p53 in vitro (Figure 2b , right panel).
The similarity between the results obtained in a cell free system and those obtained in transfected cells (Galy et al., 2001 and Figure 1 ) suggested a direct inhibition of FGF-CAT mRNA translation by wt p53.
To further characterize the repressor eect of wt p53 on FGF-CAT mRNA translation, the in vitro translation reactions were fractionated on sucrose gradients. Preincubation of radiolabelled FGF-CAT mRNA with wt p53 but not with Ala 143 mutant protein led to a weaker association of the RNA with the 80S particle in comparison to the control reaction without p53 ( Figure  2c , left panel). As expected, this eect was lost when we used CAT mRNA alone (Figure 2c, right panel) . Strikingly, when preincubated with wt p53 but not with Ala 143 the free radiolabelled RNA was mostly recovered in the heavier fractions of the gradient. This shift was independent of the RRL components since it was observed when the RNA was incubated with wt p53 alone (data not shown). Thus, it could correspond to a molecular complex containing p53 and RNA. The . 5' ± FGF corresponds to the complete leader, whereas inv 1-311 is an inversion of nucleotides 1 to 311. Expression of p53 and FGF-CAT proteins was analysed by Western immunoblotting, and the signals corresponding to FGF-CAT proteins quanti®ed by using a laser densitometer (Molecular Dynamics) as described previously (Galy et al., 2001) . Total RNA was extracted from transfected cells and the levels of FGF-CAT mRNA were determined by RNase protection assay as described previously (Galy et al., 2001) Histogram represent FGF-CAT protein levels calibrated on FGF-CAT RNA levels obtained with the dierent bigenic constructs, expressed as the ratio of FGF-CAT expression in the presence of wt 53 versus mutant Ala 143 p53. Experiments were repeated at least three times for each construct and results are expressed as means+standard error. (c) Schema of the FGF-2 mRNA leader summarizing the data of (b) black boxes represent the elements required for p53 inhibition (box I: nt 1 ± 76: box II: nt 126 ± 176; box III: nt 176 ± 221; box IV: nt 311 ± 376) whereas empty boxes correspond to dispensable elements (box A: nt 252 ± 311; box B: nt 376 ± 466) Figure 2 Eect of p53 on the synthesis of FGF-CAT proteins in a cell free system. The dierent RNAs used for in vitro translation reactions were transcribed in vitro and puri®ed as described in Materials and methods. (a) Increasing amounts (12.5, 25, 50, 100 and 200 ng) of recombinant wild-type (left panels) or mutant (Ala 143 , right panels) p53 were incubated with 20 ng of the FGF-CAT chimeric RNA (plus 0.1 ng of 32 P-labelled FGF-CAT RNA) at 378C for 15 min. Then, rabbit reticulocyte lysate containing [ 35 S]-methionine was added and the in vitro translation reactions were performed at 378C for 50 min. Half of the reaction was run on a 12% polyacrylamide SDS containing gel and then subjected to autoradiography (upper panels). The other half was used to check the integrity of the FGF-CAT RNA. RNA was isolated by phenol/chloroform extraction followed by ethanol precipitation, loaded on an agarose gel and then subjected to autoradiography (lower panels) to reveal the P-labelled FGF-CAT (left) or CAT (right) RNAs preincubated or not with wt p53 or Ala 143 and fractionated onto a 10 ± 30% linear sucrose gradient as described in Materials and methods. The radioactivity present in each fraction was counted by the Cherenkov procedure. The curves represent the amount of radioactivity recovered from each fraction as a percentage of the total radioactivity added to the reaction. The positions of free RNA and 80S particle are indicated by arrows Oncogene p53-mediated conformational change of FGF-2 mRNA B Galy et al sedimentation shift was also observed with the control CAT mRNA, but was not correlated with a change in the formation of 80S ribosome. These results showed that the ability of wt p53 to inhibit the formation of 80S ribosomal complex was speci®c to the FGF-CAT mRNA.
Both wt and mutant Ala 143 p53 interact with the FGF-2 mRNA leader
The inhibition of FGF-CAT mRNA translation in RRL might either be mediated by the action of p53 on trans-acting factors involved in control of the FGF-2 mRNA translation (i.e. by protein ± protein interactions), and/or be generated by a direct interaction of p53 with the FGF-2 mRNA. To further study the interaction of p53 with the FGF-2 mRNA leader region, recombinant p53 and a 32 P-labelled RNA corresponding to the ®rst 539 nt of FGF-2 mRNA were used in a nitrocellulose ®lter retention assay. Figure 3a shows the ecient retention activity of the FGF-2 mRNA leader by wt p53. Maximum retention was obtained for a molar ratio of about 3.5 mmole of p53 for 0.1 mmole of RNA. The Ala 143 mutant p53 was less ecient at retaining the RNA on the ®lter than equivalent amounts of wt protein.
Competition experiments were performed with dierent homologous or heterologous competitors. Results showed that CAT RNA or an FGF-2 RNA leader deleted for the ®rst 186 nt were able to compete with p53 binding as eciently as the complete FGF-2 leader (Figure 3b ) whereas wt p53 did not inhibit their translation (Figure 2b ). Furthermore, total mouse RNA was also an ecient competitor (Figure 3b) . Thus, although these data con®rmed the anity of p53 for RNA (Oberosler et al., 1993; Wu et al., 1995) , the assay failed to show any speci®c interaction between p53 and the FGF-2 RNA leader. Similar conclusions were reached after precipitating in vitro translated wt p53 or Ala 143 p53 with biotinylated RNAs corresponding to the FGF-2 RNA leader or to CAT RNA (data not shown).
The lack of speci®city in the p53/FGF-2 RNA leader interaction suggests that this interaction per se cannot explain the inhibitory eect of wt p53 on FGF-2 translation.
wt p53, but not mutant p53, generates structural changes in the FGF-2 mRNA leader p53 has been reported to exhibit nucleic acid annealing activity (Oberosler et al., 1993) . Thus, the inhibitory eect of p53 could be due to a conformational change in the FGF-2 RNA leader that prevents translation initiation. To test this hypothesis, we used DNA probes complementary to dierent parts of the FGF-2 mRNA leader to study RNA structure. The RNA/ DNA duplex can be visualized as a shift in probe mobility. The extent of duplex formation depends on the accessibility of the region complementary to the probe.
The FGF-2 RNA leader was incubated with 32 Plabelled oligonucleotides P1, P2 and P3 complementary to nt 113 to 139, 287 to 316, and 479 to 502, respectively, in the presence or not of recombinant human p53 (Figure 4a ). The annealing reaction was stopped by SDS and EDTA, thereby dissociating p53 from the nucleic acid duplex. Figure 4b shows that duplex formation occurred only in the presence of wt p53 but not of Ala 143 p53 (Figure 4b , P1, P2 and P3, lanes 5 and 6). The migration shift of the probe was dependent on the presence of the RNA (Figure 4b , P1, P2 and P3, lanes 2 and 3). Furthermore, after elimination of p53 using proteinase K, the duplexes were still observed indicating that RNA/DNA complex formation did not result from bridging of the RNA To further characterize this activity, we then studied the p53 dependent duplex formation in a dose-response assay (Figure 4c ). The results showed that 100 ng of wt p53 protein were required for maximal eect on duplex formation (Figure 4c, left panel) . This p53 amount was similar to that required for inhibition of FGF-CAT mRNA translation (Figure 2a) . In contrast, equal amounts of Ala 143 had no eect (Figure 4c, right  panel) .
We also studied kinetics of preincubation on duplex formation between the FGF-2 RNA leader and P3 probe, in parallel to kinetics of translation inhibition ( Figure 5 ). Duplex formation necessitated a preincubation time of at least 4 min, and was more ecient with longer preincubation times ( Figure 5a ). As regards translation inhibition, it was also observed after having preincubated the FGF-CAT mRNA with p53 for 4 min, and was maximal after 15 min of preincubation (Figure 5b) .
These data revealed an unwinding-annealing activity of p53 speci®c to the wild-type protein, that was able to modify the secondary structure of the FGF-2 mRNA leader. In the presence of the complete FGF-2 mRNA leader, there was a striking correlation between the kinetics of duplex formation (corresponding to the RNA structural change) and of translation inhibition.
Discussion
In this study we demonstrate that wt p53 has a translational inhibitory eect both in transfected cells and in vitro, mediated by several elements of the FGF-2 mRNA leader. We also show that direct interaction of p53 with the FGF-2 mRNA leader results in a RNA conformational change presumably generating the blockade of translation initiation.
The literature provides several elements favouring a direct action of p53 on the translational machinery. Indeed, p53 is covalently linked to the 5.8 S RNA by Ser 392 (Fontoura et al., 1997) ; it can be associated with a complex containing the 5S ribosomal RNA, the L5 ribosomal protein and mdm2 (Marechal et al., 1994) Figure 4 Eect of p53 on the accessibility of FGF-2 RNA leader regions to oligonucleotide probes. Annealing reactions were performed as described in Materials and methods (Prats et al., 1988) . and is copuri®ed with polysomal fractions (Fontoura et al., 1997) , p53 has also been reported to possess strong RNA binding and annealing activities that could modify the spatial structure of RNA (Oberosler et al., 1993) . We show here that p53 signi®cantly interacts with the FGF-2 RNA leader whereas the Ala 143 mutant has a slightly weaker RNA binding anity. However this interaction cannot alone account for the eect of p53 as it is not speci®c. Furthermore, we observed, in the nitrocellulose ®lter retention assay, that p53 binding to RNA is achieved within the ®rst minute (Galy, 2001, unpublished results) . In contrast, translation eciency is obtained after preincubation of the mRNA with p53 for at least 4 min, whereas a similar preincubation time is required for p53 to induce interactions of oligonucleotide probes with the FGF-2 mRNA leader ( Figure 5 ). The strong correlation between the kinetics of translation inhibition in RRL and appearance of a an RNA conformational change suggests that p53 could display a time-dependent helicase/hybridase activity which would modify particular structures of the FGF-2 mRNA leader, thereby blocking translation initiation. This hypothesis of translation blockade mediated by RNA structural change is supported by the requirement of several FGF-2 mRNA leader segments for translation inhibition, as shown in transfected cells (Figure 1) .
Interestingly, p53 represses the expression of all FGF-2 isoforms and this inhibition is very strong, in RRL as well as in various transfected cell lines ( Figures  1, 2 and Galy et al., 2001 ). These observations suggest that p53 abolishes both the cap-dependent and the IRES-dependent mechanisms of translation initiation that normally occur on the FGF-2 mRNA (Galy et al., 1999; Vagner et al., 1995) . We observed a sedimentation change in the wt p53/RNA complex, not observed in the presence of the Ala 143 mutant protein, for both FGF-CAT and CAT RNAs, whereas only FGF-CAT was dissociated from the 80S particle. Furthermore, wt p53 was able to induce a conformational change in an FGF-2 mRNA leader lacking the ®rst 186 nt although this modi®ed leader was no longer sensitive to the repressor eect of p53. Thus, even if we cannot rule out a steric hindrance by p53 that prevents ribosome binding, we hypothesize that the tumour suppressor could induce RNA defolding followed by compaction that would destroy the FGF-2 IRES and/or promote the formation of new inhibitory structures. Such inhibitory structures could not be formed if some particular RNA sequences were missing. The absence of a p53 eect on PDGF and VEGF-CAT fusion RNAs translation might be explained by the inability of p53 to alter the IRES structure of these messengers or to promote the formation of inhibitory structures (Galy et al., 2001) .
Previous analysis of the cellular trans-acting factors able to bind to the FGF-2 mRNA leader by UV crosslinking experiments had led us to propose that such proteins could be translational enhancers of FGF-2 expression, in particular of the CUG-initiated isoforms (Galy et al., 1999; Vagner et al., 1996) . Thus it could seem paradoxical that the ®rst trans-acting factor identi®ed for the regulation of FGF-2 expression, p53, is a silencer. One possible explanation is that translation initiation of the FGF-2 mRNA, in particular the IRES-dependent initiation, could be regulated by a balance between enhancing and silencing factors. This is in agreement with our recent observation of the stringent regulation of FGF-2 IRES activity in vivo, in transgenic mice (Creancier et al., 2000) : the strong up-regulation of this IRES in adult brain could be governed by brain speci®c enhancing factors, whereas the translational silencing observed in most other adult organs would result from the eect of an inhibitory factor. The present study suggests that such a silencer might be p53.
Materials and methods

Plasmids construction
The bigenic plasmids expressing FGF-CAT (with the complete leader) and p53 (wt or mutant) under the control of two cytomegalovirus promoters has been described previously (Galy et al., 2001) . The detailed procedure used to obtain deletions in the FGF-2 mRNA leader is available upon In vitro translation experiments were performed as described in Figure 2 , using 100 ng of p53 preincubated with 10 ng of FGF-CAT RNA during increasing times from 0 ± 15 min (as indicated at the top of the gel). The band at the top of the gel did correspond to an artefactual translation product request. For the construction of pBacp53wt and pBacp53mut, wt p53 or Ala 143 cDNAs were obtained after PCR ampli®cation of pc53-SN3 and pc53-SCX3, respectively (Baker et al., 1990) . The PCR products were inserted into pBlueBac 4.5 vector (Invitrogen) after XhoI/EcoRI digestion and were controlled by sequencing. The plasmids pSCT12VCAT, pSCTCAT used for in vitro transcription were described previously (Prats et al., 1992) . pSCTEx1CAT was constructed by insertion of the murine p53 exon 1 sequence (kindly provided by W Deppert and J Mosner) (Mosner et al., 1995) into pSCT-CAT, in 5' of the CAT ORF.
Culture of Sf9 cells and construction of recombinant baculovirus
Recombinant baculovirus vectors were constructed by using the MaxBac kit from Invitrogen. Sf9 cells were grown in supplemented Grace medium containing 10% FCS+0.1% amphotericinB+0.1% gentamicin and incubated in a 278C incubator. Cell monolayers were lipofected with viral BacNblue DNA+the pBacp53wt or pBacp53mut plasmid and recombinant viruses were isolated by plaque assay according to the manufacturer's instructions.
Production and purification of recombinant p53
Suspension cultures containing 2.10 6 exponentially growing and 495% viable cells/ml were infected with an MOI of 5 or 10 for wt p53 or Ala 143 , respectively, as determined by preliminary experiments. Cells were harvested 72 h after infection and p53 was puri®ed from nuclei of infected cells as described elsewhere (Delphin et al., 1994) except that p53 was puri®ed by using a 1 ml HiTrap Q-Sepharose column and an FPLC system from Pharmacia. The wt p53 and Ala 143 proteins were eluted at a concentration of 0.35 M NaCl and stored at 7208C in 20 mM Tris/HCl, pH 7.5, 0.2 M NaCl, 40 mM dithiothreitol, 50% glycerol (storage buer) at a ®nal concentration ranging from 60 to 300 mg/ml. The purity of p53 proteins was greater than 90% as assessed by Coomassie blue staining.
In vitro transcription and in vitro translation pSCT12VCAT, pSCTCAT and pSCTEx1CAT were linearized with Bgl II digestion and pSCTD1-186CAT with ECl136 II. Capped RNAs were synthesized by using the T7 mMessage mMachine kit from Ambion according to the manufacturer's instructions. RNAs were phenol/chloroform extracted and EtOH precipitated. Luciferase RNA was obtained from Promega. For in vitro translation, about 20 ng of each RNA was incubated with variable amounts of p53 diluted in 3 ml of storage buer. After a 15 min preincubation at 378C in a ®nal volume of 5 ml, 5 ml of lysate containing [ 35 S]-methionine were added. After a 50 min incubation at 378C, the reactions were diluted with Laemmli sample buer, heated at 958C for 3 min and then fractionated by SDS ± PAGE on a 12% polyacrylamide gel. Gels were ®xed in 40% methanol, 20% acetic acid, dried and subjected to autoradiography.
Zonal fractionation of in vitro translation reactions on sucrose gradients
FGF-CAT and CAT RNAs were transcribed in the presence of [a-32 P]CTP. In vitro translation reactions were performed as described above in 40 ml (containing 800 ng of p53 protein+80 ng of RNA) except that RRL was preincubated for 10 min at 378C in the presence of 0.5 mM cycloheximide before addition to RNAs. In vitro translation reactions were stopped after 10 min at 378C by adding 160 ml of ice-cold buer A (150 mM KOAc, 20 mM HEPES pH 7.6, 5 mM MgCl 2 , 1 mM DTT). After 15 min on ice, the reaction mixtures were loaded onto 5 ml 10 ± 30% linear sucrose gradients (in buer A) and centrifuged for 180 min at 30 000 r.p.m. in a SW-50.1 rotor (Beckman). Twenty-six fractions of 200 ml were recovered and counted by the Cerenkov procedure.
p53/FGF-2 RNA binding assay Binding of puri®ed p53 to RNA was determined by the retention of a 32 P-labelled RNA on nitrocellulose (Oberosler et al., 1993) . pSCT12VCAT and pSCTD1 ± 186CAT were linearized with EheI for the synthesis of RNA probes corresponding to nt 1 to 539 or 187 to 539 of the FGF-2 mRNA leader, respectively. Reaction mixtures (10 ml) contained increasing amounts of wild-type or mutant p53 protein plus 1 ng of 32 P-labelled FGF-2 RNA leader and were incubated for 15 min at 378C in 6 mM Tris-HCl, pH 7.5, 60 mM NaCl, 1 mM EDTA, 12 mM dithiothreitol (buer 1) and 15% glycerol. The reactions were then diluted three times in 500 ml of buer 1 and ®ltered through a 0.22 mm nitrocellulose membrane. Competition experiments were performed in the same conditions. Reaction mixtures contained 10 ng of wild-type p53 protein plus 1 ng 32 Plabelled FGF-2 RNA leader and increasing amounts of competing RNAs as indicated in the legend of Figure 3 .
Annealing of the FGF-2 RNA leader with DNA probes
Annealing reactions were performed as previously with a few modi®cations (Prats et al., 1988) : FGF-2 RNA leaders (entire or deleted for the ®rst 186 nt) were transcribed in vitro as described above. DNA oligonucleotides were 5' end labelled by using ATP-g 32 P and T4 kinase and were ethanol precipitated after phenol/chloroform extraction. P1 probe (5'-CCCGCCGGGCCGCGGCGTCACATCTTC-3') is complementary to nt 113 to 139 of the FGF-2 RNA leader, P2 probe (5'-CTCGAGCCGCTCGGCCGCTCTTCTGTCCGC-3') to nt 287 to 316 and P3 probe (5'-GTGATGCTC-CCGGCTGCCATGGTC-3') to nt 479 to 502. Ten ng of RNA were incubated with 1 ng 32 P-labelled probe with or without recombinant p53 for 15 min at 378C in 10 ml of 6 mM Tris-HCl, pH 7.5, 60 mM NaCl, 12 mM dithiothreitol. Hybridization reactions were stopped by adding SDS to 0.3% and EDTA to 15 mM, resulting in p53 removal from the RNA/DNA duplex. Samples were loaded in a non denaturing buer on a 1% agarose gel. The gel was dried and subjected to autoradiography.
